The CONTRAST Study: Understanding SFGR

the contrast study understanding more about selective fetal growth restriction taps support sfgr

In a new series of articles, we’re learning about the different research studies that are out there, making a change in the world of twins. In this article, we invited Anne Noll, PhD student to tell us more about the CONTRAST Study and selective fetal growth restriction.

About the CONTRAST study:

The CONTRAST study is a prospective multicentre international cohort study on monochorionic twins with sFGR.

Selective fetal growth restriction (sFGR) in monochorionic twins may negatively impact the pregnancy. There is a substantial risk of fetal deterioration resulting in (iatrogenic) preterm birth or even intrauterine demise of one, or both fetuses. There are important unresolved challenges on a diagnostic level and underlying pathophysiological mechanisms of sFGR have not been fully clarified.

Continue reading “The CONTRAST Study: Understanding SFGR”

Selective Reduction: A Letter From A Parent.

selective reduction taps twins twin anemia polycythemia sequence twins support

A post from a parent who went down the path of selective reduction.

This is not is a challenge to your story, or your choice, it’s just my story. It’s taken me 18mths to build up the courage to put my name to this. 

I turned to online groups in 2020 when our darling baby B, was diagnosed with sIUGR around the 19th week of pregnancy.  Our MFM and care team presented all options and of course we fought hard for both our girls. Over the next few weeks we had twice-weekly monitoring, at this point we had a 37% discordance (growing)and she was <1st%ile.

Continue reading “Selective Reduction: A Letter From A Parent.”

ORPHA… What?

twin anemia polycythemia sequence taps orpha code twins foundation stichting awareness rare disease

In January this year, Twin Anemia Polycythemia Sequence (TAPS) and 2 other diseases affecting monochorionic twins were granted an ORPHA Code and listed in the Orphanet database of rare diseases. But what does it mean that there’s an ORPHA code for TAPS?

 It’s an exciting step because it means that now, TAPS is officially listed as a rare disease and will open a lot of doors in relation to research and international collaborations and make it easier to collect data for research. 

But why is this important, and how will it help research? Let’s talk about it!

Continue reading “ORPHA… What?”

A letter to Autumn.

Autumn's Legacy

A year has passed since we said goodbye, and so much has happened.  I wanted to write to you today to tell you more about your story, and why we are passionate about Autumn’s Legacy

You are loved and will always be loved.

We miss you every day, and your sisters are sweet and spirited little girls. When I look at Leighton, I know I also see you with her.

Continue reading “A letter to Autumn.”